Skip to main content
Journal ArticleOPEN ACCESS

Multidrug-resistant hypervirulent group B streptococcus in neonatal invasive infections, France, 2007–2019

Emerging Infectious Diseases (2020) 26(11) 2721-2724
DOI: 10.3201/eid2611.201669
26Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

We analyzed group B Streptococcus (GBS) neonatal invasive infections reported during 2007–2019 in France. The hypervirulent clonal complex (CC) 17 GBS was responsible for 66% (827/1,262) of cases. The role of CC17 GBS increased over time (p for trend = 0.0001), together with the emergence of a multidrug-resistant CC17 GBS sublineage.

Cite

CITATION STYLE

APA

Plainvert, C., Hays, C., Touak, G., Joubrel-Guyot, C., Dmytruk, N., Frigo, A., … Tazi, A. (2020). Multidrug-resistant hypervirulent group B streptococcus in neonatal invasive infections, France, 2007–2019. Emerging Infectious Diseases, 26(11), 2721–2724. https://doi.org/10.3201/eid2611.201669

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free